• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biohaven Ltd (NY: BHVN )

    35.80 +1.09 (+3.14%)
    Streaming Delayed Price Updated: 9:31 AM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Biohaven Ltd

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    The 3 Smartest Healthcare Stocks to Buy With $1K Right Now
    The healthcare stocks to buy deserve more respect from investors who seek top-level growth outside of the tech sector. 
    Via InvestorPlace
    HP Posts Upbeat Earnings, Joins Foot Locker, American Superconductor, Red Robin Gourmet Burgers And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay
    Immunovant, which jumped Wednesday on news from rival Biohaven, reversed course Thursday. 
    Via Investor's Business Daily
    Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
    Biohaven shares drop as interim data from the Phase 1 study of BHV-1300 fell short of investor expectations. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    BHVN Stock Earnings: Biohaven Misses EPS for Q1 2024
    BHVN stock results show that Biohaven missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    What's Going On With Biohaven Stock Wednesday?
    The company announced it dosed a patient with a new possible treatment for certain cancers, showcased positive data from two different studies and presented other updates. 
    Via Benzinga
    Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump
    The company says it's still running additional testing of the drug, calling the results "positive." 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
    The Structure Therapeutics stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a significant upside potential. 
    Via Benzinga
    Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
    These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May. 
    Via InvestorPlace
    Around $1M Bet On Biohaven? Check Out These 4 Stocks Insiders Are Buying
    Via Benzinga
    3 Biotech Stocks to Buy on the Dip: April 2024
    With medical innovation being a resilient space, investors can have confidence with these biotech stocks to buy on the dip. 
    Via InvestorPlace
    Why Is Obesity Drug Developer Altimmune Stock Trading Lower On Wednesday?
    Latest findings on Altimmune's pemvidutide on body composition: lean mass preservation, significant weight loss from adipose tissue, and results in obesity and Metabolic dysfunction-associated... 
    Via Benzinga
    Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic... 
    Via Benzinga
    Obesity Drug Landscape Has A Contender From Biohaven, CEO Highlights Different Approach Amid Stiff Competition From Novo Nordisk, Eli Lilly
    Biohaven's approach to combat obesity. Learn about their experimental drug taldefgrobep alfa (t-alpha), targeting muscle growth regulation for effective weight loss. CEO Vlad Coric discusses its... 
    Via Benzinga
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 3/8
    Via Investor Brand Network
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 3/4
    Via Investor Brand Network
    Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
    Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy. 
    Via Investor's Business Daily
    This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
    Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion across epilepsy and mood disorders. Anticipate significant developments in lead asset... 
    Via Benzinga
    Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
    The best weight-loss drug stocks firms improving the drugs or developing new, potentially superior weight-loss treatments. 
    Via InvestorPlace
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 1/5
    Via Investor Brand Network
    Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
    Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain. 
    Via Investor's Business Daily
    FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    U.S. stock futures were lower this morning, with the Dow Jones futures falling around 30 points on Wednesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Based on good technical signals, BIOHAVEN LTD is potentially setting up for a breakout.
    BIOHAVEN LTD (NYSE:BHVN) showing some interesting technicals. Here's why. 
    Via Chartmill
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) Sets New 52-Week High in Monday Session
    Via Investor Brand Network
    Biohaven Ltd. (NYSE: BHVN) Records 52-Week High Thursday Morning
    Via Investor Brand Network
    Stock Market Rally Attempt Underway; Micron, Nike, Amazon, Meta In Focus: Weekly Review
    But it's not a confirmed uptrend yet. Nike, Amazon and Meta were in focus. 
    Via Investor's Business Daily
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.